| Literature DB >> 28087183 |
Shouhei Noshiro1, Takeshi Mikami2, Yuko Kataoka-Sasaki3, Masanori Sasaki4, Hirofumi Ohnishi5, Shunya Ohtaki1, Masahiko Wanibuchi1, Nobuhiro Mikuni6, Jeffery D Kocsis7, Osamu Honmou4.
Abstract
Cerebral cavernous malformations (CCMs) are congenital abnormal clusters of capillaries that are prone to leaking and thought to result from a disorder of endothelial cells. The underlying pathology of CCM is not fully understood. We analyzed the expression of tissue factor (TF) and interleukin-6 (IL-6) in CCMs to determine the association of TF and IL-6 with clinical and pathological findings. Thirteen cases of operative specimens of sporadic CCMs were included in this study. The expression of messenger RNA of TF and IL-6 was assayed and the association with clinical factors was investigated. Then, the distribution of TF and IL-6 was examined with immunofluorescence. The mRNA expression of TF of CCMs was significantly higher than that of the control (p=0.017), and was correlated with the number of hemorrhage appearances (p=0.190, ρ=0.62). The mRNA expression level of IL-6 was significantly correlated with the mRNA expression level of TF (p=0.034, ρ=0.58). Examination of immunostained sections indicated that TF+ cells were also positive for IL-6, and distributed around normal endothelial cells. Moreover, the TF+/IL-6+ cells expressed CD31 and VEGFR2. The expressions of IL-6 and TF were correlated, and both were present in the same immature endothelial cells. TF is elevated in CCM and might mediate progressive events. These factors may play a prognostic role in CCM.Entities:
Keywords: Cerebral cavernous malformations; Endothelial cell; Tissue factor
Mesh:
Substances:
Year: 2017 PMID: 28087183 DOI: 10.1016/j.jocn.2016.12.023
Source DB: PubMed Journal: J Clin Neurosci ISSN: 0967-5868 Impact factor: 1.961